| Literature DB >> 31817934 |
Jaeyoung Kwon1, Keebeom Ko1, Lijun Zhang2, Dong Zhao2, Hyun Ok Yang2,3, Hak Cheol Kwon1.
Abstract
Autophagy is an important self-degradative mechanism that plays a key role in treating neurodegeneration diseases. This research aimed at discovering bioactive compounds from Aster koraiensis. A new triterpene saponin, astersaponin I (1), was isolated from the EtOH extract of A. koraiensis. The structure of 1 was characterized by spectroscopic methods, ECD calculation, and acid hydrolysis. The biochemical analysis showed that compound 1 significantly increased the expression of microtubule-associated protein 1A/1B light chain 3B (LC3-II) expression in SH-SY5Y cells, which indicates the induction of autophagy. Thus, further study may be needed to clarify whether compound 1 exerts beneficial effects on neurodegeneration diseases like Parkinson's disease through autophagy induction.Entities:
Keywords: Aster koraiensis; autophagy; natural products; triterpene saponin
Mesh:
Substances:
Year: 2019 PMID: 31817934 PMCID: PMC6943805 DOI: 10.3390/molecules24244489
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
1H-NMR and 13C-NMR spectroscopic data (500 MHz) of astersaponin I (1) measured in CD3OD a.
| Position | δC | δH ( | Intensities | Position | δC | δH ( | |
|---|---|---|---|---|---|---|---|
| Aglycone | Sugar Moiety | ||||||
| 1 | 44.6 | 2.09 (dd) | 2H | Glc | 1′ | 105.3 | 4.49 (d) |
| 1.18 (dd) | 2′ | 74.7 | 3.48 (m) | ||||
| 2 | 71.3 | 4.33 (m) | 1H | 3′ | 88.1 | 3.52 (m) | |
| 3 | 84.2 | 3.63 (m) | 1H | 4′ | 71.1 | 3.51 (m) | |
| 4 | 43.3 | 5′ | 77.5 | 3.31 (m) | |||
| 5 | 48.5 | 1.33 (m) | 1H | 6′ | 62.3 | 3.81 (m) | |
| 6 | 18.9 | 1.50 (m) | 2H | 3.71 (m) | |||
| 7 | 34.0 | 1.67 (m) | 2H | Xyl I | 1′′ | 106.2 | 4.51(d) |
| 1.35 (m) | 2′′ | 73.2 | 3.64 (m) | ||||
| 8 | 41.0 | 1H | 3′′ | 76.3 | 3.23 (m) | ||
| 9 | 48.7, | 1.63 (m) | 1H | 4′′ | 70.2 | 3.81 (m) | |
| 10 | 37.7 | 5′′ | 67.6 | 3.87 (d) | |||
| 11 | 24.8 | 2.00, (m) | 2H | 3.57 (d) | |||
| 1.96 (m) | Ara | 1′′ | 94.1 | 5.63 (br d) | |||
| 12 | 123.9 | 5.38, (br t) | 1H | 2′′′ | 75.6 | 3.78 (dd) | |
| 13 | 144.9 | 3′′′ | 70.6 | 3.91 (m) | |||
| 14 | 43.1 | 4′′′ | 66.8 | 3.84 (m) | |||
| 15 | 36.5 | 1.78 (m) | 2H | 5′′′ | 63.4 | 3.92 (m) | |
| 1.39 (m) | 3.49 (m) | ||||||
| 16 | 74.8 | 4.49 (d) | 1H | Rha I | 1′′′′ | 101.0 | 5.00 (br d) |
| 17 | 50.5 | 2′′′′ | 72.3 | 4.07 (m) | |||
| 18 | 42.3 | 3.06 (br dd) | 1H | 3′′′′ | 82.7 | 3.87 (m) | |
| 19 | 47.8 | 2.28 (br dd) | 2H | 4′′′′ | 78.9 | 3.69 (m) | |
| 1.04 (br dd) | 5′′′′ | 69.2 | 3.71 (m) | ||||
| 20 | 31.5 | 6′′′′ | 18.5 | 1.27 (d) | |||
| 21 | 36.6, | 1.93 (m) | 2H | Xyl II | 1′′′′′ | 105.0 | 4.74 (d) |
| 1.16 (m) | 2′′′′′ | 75.4 | 3.29 (m) | ||||
| 22 | 32.1 | 1.92 (m) | 2H | 3′′′′′ | 84.5 | 3.41 (m) | |
| 1.80 (m) | 4′′′′′ | 70.4 | 3.50 (m) | ||||
| 23 | 66.0 | 3.63 (m) | 2H | 5′′′′′ | 67.1 | 3.86 (m) | |
| 3.24 (m) | 3.20 (m) | ||||||
| 24 | 15.0 | 0.95 (s) | 3H | Rha II | 1′′′′′′ | 102.8 | 5.14 (br d) |
| 25 | 17.8 | 1.31 (s) | 3H | 2′′′′′′ | 72.4 | 3.93 (m) | |
| 26 | 18.2 | 0.80 (s) | 3H | 3′′′′′′ | 72.4 | 3.70 (m) | |
| 27 | 27.5 | 1.38 (s) | 3H | 4′′′′′′ | 74.1 | 3.40 (m) | |
| 28 | 177.2 | 5′′′′′′ | 70.1 | 4.02 (m) | |||
| 29 | 25.3 | 0.98 (s) | 3H | 6′′′′′′ | 18.0 | 1.24 (d) | |
| 30 | 33.5 | 0.89 (s) | 3H | Xyl III | 1′′′′′′′ | 106.3 | 4.50 (d) |
| 2′′′′′′′ | 75.4 | 3.28 (m) | |||||
| 3′′′′′′′ | 77.8 | 3.32 (m) | |||||
| 4′′′′′′′ | 71.1 | 3.50 (m) | |||||
| 5′′′′′′′ | 67.3 | 3.91 (m) | |||||
| 3.25 (m) |
a The respective chemical shifts in ppm are indicated by δ. Multiplicities are indicated by s (singlet), d (doublet), and m (multiplet) including coupling constant J in Hz.
Figure 1Key HMBC (A) and ROESY (B) correlations of astersaponin I (1).
Figure 2Measured and theoretical ECD spectra of astersaponin I (1).
Figure 3Chemical structure of astersaponin I (1).
Figure 4(A) The LC3-II expression patterns upon treatment of EtOH extract (12.5, 25, and 50 μg/mL), n-hexane (12.5 μg/mL), EtOAc (12.5, 25, and 50 μg/mL), and n-BuOH (12.5, 25, and 50 μg/mL) fractions. (B) The up-regulated LC3-II expression in dose-dependent manner by treatment with compound 1. (C) The representative western blot bands of protein marker LC3 in SH-SY5Y cells treated with EtOH extract, fractions (n-hexane, EtOAc n-BuOH), and compound 1. Data are expressed as mean ± SEM (n = 3). ** p < 0.01, *** p < 0.001 significant difference from control.